Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma
Open accessThe DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
Emerging evidence suggests that both human stem cells and mature stromal cells can play an important role in the development and growth of human malignancies. In contrast to these tumor-promoting properties, we observed that in an in vivo model of Kaposi's sarcoma (KS), intravenously (i.v.) injected human mesenchymal stem cells (MSCs) home to sites of tumorigenesis and potently inhibit tumor growth. We further show that human MSCs can inhibit the in vitro activation of the Akt protein kinase within some but not all tumor and primary cell lines. The inhibition of Akt activity requires the MSCs to make direct cell–cell contact and can be inhibited by a neutralizing antibody against E-cadherin. We further demonstrate that in vivo, Akt activation within KS cells is potently down-regulated in areas adjacent to MSC infiltration. Finally, the in vivo tumor-suppressive effects of MSCs correlates with their ability to inhibit target cell Akt activity, and KS tumors engineered to express a constitutively activated Akt construct are no longer sensitive to i.v. MSC administration. These results suggest that in contrast to other stem cells or normal stromal cells, MSCs possess intrinsic antineoplastic properties and that this stem cell population might be of particular utility for treating those human malignancies characterized by dysregulated Akt.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“There they can potentiate further tumorigenesis via differentiation into tumor-nurturing stroma (TAF, myofibroblasts) [82, 104], direct cell contact interaction with cancer cells [105, 106] or release of paracrine factors (Table 2).”
From Mesenchymal stem cell secretome and regenerative therapy after cancer (2013) · cites this paper as [106]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The anti-tumorigenic and pro-apoptotic effect of MSCs results from the suppression of the phosphoinositide 3-kinase/protein kinase B (PI3K/Akt) signaling pathway in some cancer types [59].”
From Mesenchymal stromal cells for bone sarcoma treatment: Roadmap to clinical practice (2019) · cites this paper as [59]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Existing data from pre-clinical studies regarding the pro-apoptotic effect of MSCs on cancer cells through the downregulation of PI3K/Akt pathway support this antitumor potential in hepatocellular carcinoma, glioma cells, Kaposi's sarcoma, and prostate and breast cancer [61], [62], [63], [64], [65].”
From Mesenchymal stromal cells for bone sarcoma treatment: Roadmap to clinical practice (2019) · cites this paper as [61]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multilineage potential of adult human mesenchymal stem cells
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., & Marshak, D. R. (1999) · Science · doi:10.1126/science.284.5411.143 · Cited by 21,052
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Identification of Herpesvirus-Like DNA Sequences in AIDS-Sssociated Kaposi's Sarcoma
Chang, Y., Cesarman, E., Pessin, M. S., Lee, F., Culpepper, J., Knowles, D. M., & Moore, P. S. (1994) · Science · doi:10.1126/science.7997879 · Cited by 5,654
Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues
Prockop, D. J. (1997) · Science · doi:10.1126/science.276.5309.71 · Cited by 4,629
Human mesenchymal stem cells modulate allogeneic immune cell responses
Aggarwal, S., & Pittenger, M. F. (2005) · Blood · doi:10.1182/blood-2004-04-1559 · Cited by 4,511
Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Regulation of neuronal survival by the serine-threonine protein kinase Akt
Dudek, H., Datta, S. R., Franke, T. F., Birnbaum, M. J., Yao, R., Cooper, G. M., Segal, R. A., Kaplan, D. R., & Greenberg, M. E. (1997) · Science · doi:10.1126/science.275.5300.661 · Cited by 2,436 · cited 1×
“The myristoylated Akt plasmid (myrAkt) has been previously described (49)”
BackgroundStromal fibroblasts in cancer initiation and progression
Bhowmick, N. A., Neilson, E. G., & Moses, H. L. (2004) · Nature · doi:10.1038/nature03096 · Cited by 2,302
Chen, J., Li, Y., Wang, L., Zhang, Z., Lu, D., Lu, M., & Chopp, M. (2001) · Stroke · doi:10.1161/01.str.32.4.1005 · Cited by 1,764
Le Blanc, K., Tammik, C., Rosendahl, K., Zetterberg, E., & Ringdén, O. (2003) · Experimental Hematology · doi:10.1016/s0301-472x(03)00110-3 · Cited by 1,623
Cited by
Items 201–300 of 747
Ohta, N., Ishiguro, S., Kawabata, A., Uppalapati, D., Pyle, M., Troyer, D., De, S., Zhang, Y., Becker, K. G., & Tamura, M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0123756 · Cited by 70
Multipotent mesenchymal stromal cells and rheumatoid arthritis: risk or benefit?
Bouffi, C., Djouad, F., Mathieu, M., Noel, D., & Jorgensen, C. (2009) · Rheumatology · doi:10.1093/rheumatology/kep162 · Cited by 70
The Tumor Stroma as Mediator of Drug Resistance - A Potential Target to Improve Cancer Therapy?
Sebens, S., & Schafer, H. (2012) · Current Pharmaceutical Biotechnology · doi:10.2174/138920112802501999 · Cited by 69
Yuan, Z., Kolluri, K. K., Sage, E. K., Gowers, K. H. C., & Janes, S. M. (2015) · Cytotherapy · doi:10.1016/j.jcyt.2015.03.603 · Cited by 69
Organ-specific migration of mesenchymal stromal cells: Who, when, where and why?
Cornelissen, A. S., Maijenburg, M. W., Nolte, M. A., & Voermans, C. (2015) · Immunology Letters · doi:10.1016/j.imlet.2015.06.019 · Cited by 75
Moniri, M. R., Sun, X.-Y., Rayat, J., Dai, D., Ao, Z., He, Z., Verchere, C. B., Dai, L.-J., & Warnock, G. L. (2012) · Cancer Gene Therapy · doi:10.1038/cgt.2012.46 · Cited by 74
Human adipose tissue-derived mesenchymal stem cells inhibit melanoma growth in vitro and in vivo.
Ahn, J., Coh, Y.-R., Lee, H. W., Shin, I.-S., Kang, S., & Youn, H. (2015) · PubMed · Cited by 68
Stem cell-based regenerative opportunities for the liver: State of the art and beyond
Tsolaki, E. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i43.12334 · Cited by 68
The versatile role of exosomes in cancer progression: diagnostic and therapeutic implications
Sundararajan, V., Sarkar, F. H., & Ramasamy, T. S. (2018) · Cellular Oncology · doi:10.1007/s13402-018-0378-4 · Cited by 67
Javan, M. R., Khosrojerdi, A., & Moazzeni, S. M. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00840 · Cited by 67
Dittmer, A., Hohlfeld, K., Lützkendorf, J., Müller, L. P., & Dittmer, J. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0089-0 · Cited by 76
Liu, J., Han, G., Liu, H., & Qin, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062844 · Cited by 70
Ahn, J. O., Lee, H. W., Seo, K., Kang, S. K., Ra, J. C., & Youn, H. Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074897 · Cited by 71
Hashemian, S. J., Kouhnavard, M., & Nasli‐Esfahani, E. (2015) · Journal of Diabetes Research · doi:10.1155/2015/675103 · Cited by 73
Kalimuthu, S., Zhu, L., Oh, J. M., Gangadaran, P., Lee, H., Baek, S. H., Rajendran, R. L., Gopal, A., Jeong, S. Y., Lee, S., et al. (2018) · International Journal of Medical Sciences · doi:10.7150/ijms.25760 · Cited by 67
Ge, X., Liu, W., Zhao, W., Feng, S., Duan, A., Ji, C., Shen, K., Liu, W., Zhou, J., Jiang, D., et al. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.07.025 · Cited by 64
Effects of Mesenchymal Stromal Cell-Derived Extracellular Vesicles on Tumor Growth
Bruno, S., Collino, F., Iavello, A., & Camussi, G. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00382 · Cited by 63
QIAO, L., ZHAO, T.-J., WANG, F.-Z., SHAN, C.-L., YE, L.-H., & ZHANG, X.-D. (2008) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2008.00751.x · Cited by 63
Yang, X. F., Hou, J., Han, Z., Wang, Y., Hao, C., Wei, L., & Shi, Y. (2013) · Cell & Bioscience · doi:10.1186/2045-3701-3-5 · Cited by 65
Bone Marrow–Derived Mesenchymal Stromal Cells Promote Survival and Drug Resistance in Tumor Cells
Bergfeld, S. A., Blavier, L., & DeClerck, Y. A. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0400 · Cited by 63
Chien, L., Hsiao, J., Hsu, S.-C., Yao, M., Lu, C., Liu, H., Chen, Y., Yang, C., & Huang, D. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.01.042 · Cited by 64
Mesenchymal stem cells as a gene therapy carrier for treatment of fibrosarcoma
Xiang, J., Tang, J., Song, C., Yang, Z., Hirst, D. G., Zheng, Q., & Li, G. (2009) · Cytotherapy · doi:10.1080/14653240902960429 · Cited by 69
Bu, S., Wang, Q., Zhang, Q., Sun, J., He, B., Xiang, C., Liu, Z., & Lai, D. (2016) · Scientific Reports · doi:10.1038/srep37019 · Cited by 66
MSC and Tumors: Homing, Differentiation, and Secretion Influence Therapeutic Potential
D’souza, N., Burns, J. S., Grisendi, G., Candini, O., Veronesi, E., Piccinno, S., Horwitz, E. M., Paolucci, P., Conte, P., & Dominici, M. (2012) · Advances in Biochemical Engineering/Biotechnology · doi:10.1007/10_2012_150 · Cited by 61
To grab the stroma by the horns: From biology to cancer therapy with mesenchymal stem cells
Droujinine, I. A., Eckert, M. A., & Zhao, W. (2013) · Oncotarget · doi:10.18632/oncotarget.1040 · Cited by 69
Immunomodulatory Nature and Site Specific Affinity of Mesenchymal Stem Cells: a Hope in Cell Therapy
Lotfinejad, P., Shamsasenjan, K., Movassaghpour, A. A., Majidi, J., & Baradaran, B. (2013) · Europe PMC (PubMed Central) · doi:10.5681/apb.2014.002 · Cited by 70
Thymidine Kinase Gene Modified Bone Marrow Mesenchymal Stem Cells as Vehicles for Antitumor Therapy
Song, C., Xiang, J., Tang, J., Hirst, D. G., Zhou, J., Chan, K.-M., & Li, G. (2010) · Human Gene Therapy · doi:10.1089/hum.2010.116 · Cited by 64
Immune Plasticity of Bone Marrow-Derived Mesenchymal Stromal Cells
Stagg, J., & Galipeau, J. (2007) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-68976-8_3 · Cited by 62
Mesenchymal stem cells as cellular vehicles for prodrug gene therapy against tumors
Amara, I., Touati, W., Beaune, P. H., & de Waziers, I. (2014) · Biochimie · doi:10.1016/j.biochi.2014.06.016 · Cited by 68
Engineered Mesenchymal Stem Cells as an Anti-Cancer Trojan Horse
Nowakowski, A., Drela, K., Rozycka, J., Janowski, M., & Lukomska, B. (2016) · Stem Cells and Development · doi:10.1089/scd.2016.0120 · Cited by 60
Mesenchymal stem cells confer chemoresistance in breast cancer via a CD9 dependent mechanism
Ullah, M., Akbar, A., Ng, N. N., Concepcion, W., & Thakor, A. S. (2019) · Oncotarget · doi:10.18632/oncotarget.26952 · Cited by 62
Zhang, X., Tu, H., Yang, Y., Fang, L., Wu, Q., & Li, J. (2017) · Stem Cells International · doi:10.1155/2017/1758139 · Cited by 59
Inhibitory effect and mechanism of mesenchymal stem cells on liver cancer cells
Hou, L., Wang, X., Zhou, Y., Ma, H., Wang, Z., He, J., Hu, H., Guan, W., & Ma, Y. (2013) · Tumor Biology · doi:10.1007/s13277-013-1165-5 · Cited by 59
Mesenchymal Stem Cells in the Pathogenesis and Therapy of Breast Cancer
El-Haibi, C. P., & Karnoub, A. E. (2010) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-010-9196-7 · Cited by 66
Stem cell therapy for inflammatory bowel disease
Nagaishi, K., Arimura, Y., & Fujimiya, M. (2015) · Journal of Gastroenterology · doi:10.1007/s00535-015-1040-9 · Cited by 65
Tumor promotion through the mesenchymal stem cell compartment in human hepatocellular carcinoma
Hernanda, P. Y., Pedroza-Gonzalez, A., van der Laan, L. J. W., Bröker, M. E. E., Hoogduijn, M. J., Ijzermans, J. N. M., Bruno, M. J., Janssen, H. L. A., Peppelenbosch, M. P., & Pan, Q. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt210 · Cited by 58
Immune properties of mesenchymal stem cells
Sotiropoulou, P. A., & Papamichail, M. (2007) · Methods in Molecular Biology · doi:10.1007/978-1-59745-536-7_16 · Cited by 57
Liu, H., Deng, S., Han, L., Ren, Y., Gu, J., He, L., Liu, T., & Yuan, Z. (2021) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2021.112163 · Cited by 63
Slama, Y., Ah-Pine, F., Khettab, M., Arcambal, A., Begue, M., Dutheil, F., & Gasque, P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713511 · Cited by 57
Mesenchymal stem cells inhibit multiple myeloma cells via the Fas/Fas ligand pathway
Atsuta, I., Liu, S., Miura, Y., Akiyama, K., Chen, C., An, Y., Shi, S., & Chen, F.-M. (2013) · Stem Cell Research & Therapy · doi:10.1186/scrt322 · Cited by 57
“showing that infused MSCs moved immediately to the tumor site [62].”
BackgroundAdipose-Derived Stem Cells Inhibit the Contractile Myofibroblast in Dupuytrenʼs Disease
Verhoekx, J. S. N., Mudera, V., Walbeehm, E. T., & Hovius, S. E. R. (2013) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0b013e3182a3bf2b · Cited by 67
Han, I., Yun, M., Kim, E.-O., Kim, B., Jung, M.-H., & Kim, S.-H. (2014) · Stem Cell Research & Therapy · doi:10.1186/scrt443 · Cited by 56
RetractedMesenchymal stromal/stem cells in drug therapy: New perspective
Sherman, L. S., Shaker, M., Mariotti, V., & Rameshwar, P. (2016) · Cytotherapy · doi:10.1016/j.jcyt.2016.09.007 · Cited by 65
Extracellular acidity strengthens mesenchymal stem cells to promote melanoma progression
Peppicelli, S., Bianchini, F., Toti, A., Laurenzana, A., Fibbi, G., & Calorini, L. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1078032 · Cited by 68
Motaln, H., Gruden, K., Hren, M., Schichor, C., Primon, M., Rotter, A., & Lah, T. T. (2012) · Cell Transplantation · doi:10.3727/096368912x640547 · Cited by 58
Concise Review: Vascular Stem Cells and Tumor Angiogenesis
Melero‐Martin, J. M., & Dudley, A. C. (2011) · Stem Cells · doi:10.1002/stem.583 · Cited by 63
Inhibition of lung cancer cell proliferation mediated by human mesenchymal stem cells
Li, L., Tian, H., Chen, Z., Yue, W., Li, S., & Li, W. (2011) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmq118 · Cited by 59
Tian, K. V., Yang, S., Ren, Q., Han, Z., Lu, S., Ma, F., Zhang, L., & Han, Z. (2010) · Cellular Physiology and Biochemistry · doi:10.1159/000323973 · Cited by 61
Sasaki, T., Mizuochi, C., Horio, Y., Nakao, K., Akashi, K., & Sugiyama, D. (2010) · Development · doi:10.1242/dev.051359 · Cited by 65
Doi, C., Maurya, D. K., Pyle, M. M., Troyer, D. L., & Tamura, M. (2010) · Cytotherapy · doi:10.3109/14653240903548194 · Cited by 54
Sun, B., Yu, K., Bhandari, D. R., Jung, J., Kang, S., & Kang, K. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.04.007 · Cited by 58
Wang, J., Bian, C., Liao, L., Zhu, Y., Li, J., Zeng, L., & Zhao, R. C. (2009) · Hepatology Research · doi:10.1111/j.1872-034x.2009.00564.x · Cited by 54
The dual effect of mesenchymal stem cells on tumour growth and tumour angiogenesis
Kéramidas, M., de Fraipont, F., Karageorgis, A., Moisan, A., Persoons, V., Richard, M., Coll, J., & Rome, C. (2013) · Stem Cell Research & Therapy · doi:10.1186/scrt195 · Cited by 58
Grisendi, G., Bussolari, R., Veronesi, E., Piccinno, M. S., Burns, J. S., Santis, G. D., Loschi, P., Pignatti, M., Benedetto, F. D., Ballarin, R., et al. (2011) · Europe PMC (PubMed Central) · Cited by 64
Song, N., Gao, L., Qiu, H., Huang, C., Cheng, H., Zhou, H., Lv, S., Chen, L., & Wang, J. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2191 · Cited by 59
Jiao, H., Guan, F., Yang, B., Li, J., Song, L., Hu, X., & Du, Y. (2011) · Molecular Biology Reports · doi:10.1007/s11033-011-0760-z · Cited by 53
Lin, H. D., Fong, C., Biswas, A., Choolani, M. A., & Bongso, A. (2014) · Stem Cell Reviews and Reports · doi:10.1007/s12015-014-9514-3 · Cited by 54
Pleiotropic effects of cancer cells’ secreted factors on human stromal (mesenchymal) stem cells
Al-Toub, M., Almusa, A., Almajed, M., Al-Nbaheen, M. S., Kassem, M. S., Aldahmash, A. M., & Alajez, N. M. (2013) · Stem Cell Research & Therapy · doi:10.1186/scrt325 · Cited by 55
Mesenchymal Stem Cells: A New Promise in Anticancer Therapy
Ciavarella, S., Dominici, M., Dammacco, F., & Silvestris, F. (2010) · Stem Cells and Development · doi:10.1089/scd.2010.0223 · Cited by 53
Timin, A. S., Peltek, O. O., Zyuzin, M. V., Muslimov, A. R., Karpov, T. E., Epifanovskaya, O. S., Shakirova, A. I., Zhukov, M. V., Tarakanchikova, Y. V., Lepik, K. V., et al. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b22685 · Cited by 52
McGrail, D. J., Ghosh, D., Quach, N. D., & Dawson, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033248 · Cited by 53
Romano, B., Elangovan, S., Erreni, M., Sala, E., Petti, L., Kunderfranco, P., Massimino, L., Restelli, S., Sinha, S., Lucchetti, D., et al. (2019) · Stem Cells · doi:10.1002/stem.3010 · Cited by 53
Xiong, N., Cao, X., Zhang, Z., Huang, J., Chen, C., Zhang, Z., Jia, M., Xiong, J., Liang, Z., Sun, S., et al. (2010) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2010.06.004 · Cited by 53
Mesenchymal Stem Cells for Anti-Cancer Drug Delivery
Ackova, D. G., Zaidman, N. A., & Bosnakovski, D. (2013) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/15748928113089990040 · Cited by 52
Encapsulated stem cells for cancer therapy
Shah, K. (2013) · Biomatter · doi:10.4161/biom.24278 · Cited by 50
Serhal, R., Saliba, N., Hilal, G., Moussa, M., Hassan, G. S., Atat, O. E., & Alaaeddine, N. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i5.567 · Cited by 54
Mesenchymal Stem Cells Cancel Azoxymethane-Induced Tumor Initiation
Nasuno, M., Arimura, Y., Nagaishi, K., Isshiki, H., Onodera, K., Nakagaki, S., Watanabe, S., Idogawa, M., Yamashita, K., Naishiro, Y., et al. (2013) · Stem Cells · doi:10.1002/stem.1594 · Cited by 52
Kim, N., Nam, Y.-S., Im, K.-I., Lim, J.-Y., Lee, E., Jeon, Y., & Cho, S. (2015) · Stem Cells and Development · doi:10.1089/scd.2015.0103 · Cited by 50
Yun, J.-W., Ahn, J. H., Kwon, E., Kim, S. H., Kim, H., Jang, J., Kim, W. H., Kim, J. H., Han, S.-Y., Kim, J. T., et al. (2016) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2016.09.029 · Cited by 52
Li, W., Han, Y., Zhao, Z., Ji, X., Wang, X., Jin, J., Wang, Q., Guo, X. Y., Cheng, Z., Lu, M., et al. (2019) · International Journal of Oncology · doi:10.3892/ijo.2019.4756 · Cited by 55
Mesenchymal Progenitors Expressing TRAIL Induce Apoptosis in Sarcomas
Grisendi, G., Spano, C., D'souza, N., Rasini, V., Veronesi, E., Prapa, M., Petrachi, T., Piccinno, S., Rossignoli, F., Burns, J. S., et al. (2015) · STEM CELLS · doi:10.1002/stem.1903 · Cited by 48
LIGHT Delivery to Tumors by Mesenchymal Stem Cells Mobilizes an Effective Antitumor Immune Response
Zou, W., Zheng, H., He, T., Chang, J., Fu, Y., & Fan, W. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-4216 · Cited by 53
Pelagalli, A., Nardelli, A., Fontanella, R., & Zannetti, A. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17071102 · Cited by 48
CHENG, J., LI, L., LIU, Y., WANG, Z., ZHU, X., & BAI, X. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2012.1019 · Cited by 48
Human embryonic stem cells secrete soluble factors that inhibit cancer cell growth
Giuffrida, D., Rogers, I. M., Nagy, A., Calogero, A. E., Brown, T. J., & Casper, R. F. (2009) · Cell Proliferation · doi:10.1111/j.1365-2184.2009.00640.x · Cited by 47
Tolerance in Organ Transplantation: From Conventional Immunosuppression to Extracellular Vesicles
Tortajada, M., Lauzurica, R., & Borràs, F. E. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00416 · Cited by 55
Interaction of human adipose tissue-derived mesenchymal stromal cells with breast cancer cells
KUCEROVA, L., KOVACOVICOVA, M., POLAK, S., BOHAC, M., FEDELES, J., PALENCAR, D., & MATUSKOVA, M. (2011) · Neoplasma · doi:10.4149/neo_2011_05_361 · Cited by 47
Mesenchymal stem cell-mediated cancer therapy: A dual-targeted strategy of personalized medicine
Sun, X., Nong, J., Qin, K., Warnock, G. L., & Dai, L. (2011) · World Journal of Stem Cells · doi:10.4252/wjsc.v3.i11.96 · Cited by 48
Liu, C., Billet, S., Choudhury, D., Cheng, R., Haldar, S., Fernandez, A., Biondi, S., Liu, Z., Zhou, H., & Bhowmick, N. A. (2020) · Neoplasia · doi:10.1016/j.neo.2020.11.012 · Cited by 51
Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma
Khakoo, A. Y., Pati, S., Anderson, S. A., Reid, W. C., Elshal, M. F., Rovira, I. I., Nguyen, A. T., Malide, D. A., Combs, C. A., Hall, G., et al. (2006) · The Journal of Cell Biology · doi:10.1083/jcb1734oia7 · Cited by 47
Self-citationGu, J., Hoj, J. P., Rouse, C., & Pendergast, A. M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0241423 · Cited by 53
Chung, T., Hsiao, J., Hsu, S.-C., Yao, M., Chen, Y., Wang, S., Kuo, M. Y., Yang, C., & Huang, D. (2011) · ACS Nano · doi:10.1021/nn2033902 · Cited by 46
Inhibition of intracranial glioma growth by endometrial regenerative cells
Han, X., Meng, X., Yin, Z., Rogers, A., Zhong, J. M., Rillema, P., Jackson, J. A., Ichim, T. E., Minev, B., Carrier, E., et al. (2009) · Cell Cycle · doi:10.4161/cc.8.4.7731 · Cited by 48
In vitro Culture of Naïve Human Bone Marrow Mesenchymal Stem Cells: A Stemness Based Approach
Pal, B., & Das, B. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00069 · Cited by 52
Fonseka, M., Ramasamy, R., Tan, B. C., & Seow, H. F. (2012) · Cell Biology International · doi:10.1042/cbi20110595 · Cited by 49
Evolving trends in stem cell therapy: an emerging and promising approach against various diseases
Abusalah, M. A. H., Priyanka, Rahman, E. N. S. E. A., & Choudhary, O. P. (2024) · International Journal of Surgery · doi:10.1097/js9.0000000000001948 · Cited by 54
Ma, S., Liang, S., Jiao, H., Chi, L., Shi, X., Tian, Y., Yang, B., & Guan, F. (2014) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1836-y · Cited by 45
“For example, a tumor inhibitory effect of human bone marrowderived MSCs on Kaposi’s sarcoma has been reported [9].”
BackgroundResultInfluence of mesenchymal stem cells on metastasis development in mice in vivo
Meleshina, A. V., Cherkasova, E. I., Shirmanova, M. V., Klementieva, N. V., Kiseleva, E. V., Snopova, L. В., Prodanets, N. N., & Zagaynova, E. V. (2015) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0003-7 · Cited by 45
Matrix elasticity regulates mesenchymal stem cell chemotaxis
Saxena, N., Mogha, P., Dash, S., Majumder, A., Jadhav, S., & Sen, S. (2018) · Journal of Cell Science · doi:10.1242/jcs.211391 · Cited by 47
Mesenchymal Stem Cell Expressing TRAIL as Targeted Therapy against Sensitised Tumour
Fakiruddin, K. S., Ghazalli, N., Lim, M. N., Zakaria, Z., & Abdullah, S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082188 · Cited by 47
Mohme, M., Maire, C. L., Geumann, U., Schliffke, S., Dührsen, L., Fita, K. D., Akyüz, N., Binder, M., Westphal, M., Guenther, C., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-0803 · Cited by 47
The potential of mesenchymal stem cells in the management of radiation enteropathy
Chang, P.-Y., Qu, Y.-Q., Wang, J., & Dong, L.-H. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.189 · Cited by 48
Inhibition of uPAR-TGFβ crosstalk blocks MSC-dependent EMT in melanoma cells
Laurenzana, A., Biagioni, A., Bianchini, F., Peppicelli, S., Chillà, A., Margheri, F., Luciani, C., Pimpinelli, N., Rosso, M. D., Calorini, L., et al. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1266-2 · Cited by 47
Lee, W., Zhang, T., Lau, C., Wang, C. C., Chan, K., & Li, G. (2013) · Cytotherapy · doi:10.1016/j.jcyt.2013.06.010 · Cited by 47
Cellular mechanisms of emerging applications of mesenchymal stem cells.
Mok, P. L., Leong, C. F., & Cheong, S. (2013) · PubMed · Cited by 48
Rabin, N. K., Kyriakou, C. A., Coulton, L., Gallagher, O., Buckle, C., Benjamin, R., Singh, N., Glassford, J., Otsuki, T., Nathwani, A. C., et al. (2007) · Leukemia · doi:10.1038/sj.leu.2404814 · Cited by 45
Improving Autologous Fat Grafting in Regenerative Surgery through Stem Cell-Assisted Lipotransfer
Debuc, B., Gendron, N., Cras, A., Rancic, J., Philippe, A., Cetrulo, C. L., Lellouch, A. G., & Smadja, D. M. (2023) · Stem Cell Reviews and Reports · doi:10.1007/s12015-023-10568-4 · Cited by 55
Zhao, W., Ren, G., Zhang, L., Zhang, Z., Liu, J., Kuang, P., Yin, Z., & Wang, X. (2012) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2011.1150 · Cited by 49
Mesenchymal Stem Cell Therapy in Diabetes Mellitus: Progress and Challenges
El‐Badri, N., & Ghoneim, M. A. (2013) · Journal of Nucleic Acids · doi:10.1155/2013/194858 · Cited by 47
Classification and biology of tumour associated stromal cells
Raffaghello, L., & Dazzi, F. (2015) · Immunology Letters · doi:10.1016/j.imlet.2015.06.016 · Cited by 66
Metadata
- Authors
- Khakoo, A. Y., Pati, S., Anderson, S. A., Reid, W., Elshal, M. F., Rovira, I. I., Nguyen, A. T., Malide, D., Combs, C. A., Hall, G., Zhang, J., Raffeld, M., Rogers, T. B., Stetler-Stevenson, W., Frank, J. A., Reitz, M., & Finkel, T.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- University of Maryland Biotechnology Institute (US)
- National Institutes of Health (US)
- Flow Cytometry Core Facility (CH)
- 1Laboratory of Molecular Biology, Cardiovascular Branch,
- National Heart, Lung, and Blood Institute (US)
- University of Maryland, Baltimore (US)
- National Cancer Institute (UA)
- 4National Cancer Institute; and
- ORCID
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2006-04-24
- Volume
- 203
- Issue
- 5
- Pages
- 1235-1247
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2121206
- OpenAlex
- W2163234891
- Cited by
- 747
- References
- 60
- Citations by year
- 2026: 6 · 2025: 16 · 2024: 20 · 2023: 31 · 2022: 25 · 2021: 34 · 2020: 37 · 2019: 41 · 2018: 38 · 2017: 28 · 2016: 53 · 2015: 56 · 2014: 38 · 2013: 79 · 2012: 51
- FWCI
- 14.63
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute
- National Cancer Institute (1R01 CA09905-01)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- mesenchymal stem cells, Kaposi's sarcoma, anticancer activity, Akt signaling, E-cadherin, cell-cell contact, tumor stroma, stem cell homing, tumor suppression, stem cell therapy
- MeSH terms
- Animals, Disease Models, Animal, Enzyme Activation, Male, Mice, Nude, Neoplasm Transplantation, Neoplasms, Experimental, Sarcoma, Kaposi, Transplantation, Heterologous, Tumor Cells, Cultured, Stromal Cells, Graft vs Tumor Effect, Mesenchymal Stem Cell Transplantation, Oncogene Protein v-akt, Mice, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.